ArticleBMJ open2018

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study.

Holger Reinecke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.